Skip to main content
TipRanks
Go Ultimate75% OFF

Steve Myers Insider Profile

4 Followers

Steve Myers, former Director at Advanced Oncotherapy, holds 1.61M shares in Advanced Oncotherapy (Ticker: GB:AVO). Most recently, Steve Myers Bought 70,000 shares of Advanced Oncotherapy on Dec 29, 2022 for an estimated value of 8.75K .

Steve Myers's Trading History

AVO
Advanced Oncotherapy
Dec 29, 2022―Informative Buy8.75K£28.18K
GB:AVO
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Dec 29, 2022Informative Buy£8.75K70,000£12.00-86.70%―
Mar 04, 2022Informative Buy£38.70K140,000£28.00-81.20%―
Aug 11, 2021Uninformative Buy£0.00416,667£0.00――
Apr 09, 2020Uninformative Buy£50.00K200,000£25.00――
May 15, 2017Informative Buy£104.00K400,000£26.00+103.60%―

You May Also Like

Steve Myers insider profile FAQ

What is the percentage of profitable transactions made by Steve Myers?
The percentage of profitable transactions made by Steve Myers is 33%.
What is the average return per transaction made by Steve Myers?
The average return per transaction made by Steve Myers is -21.40%.
What stocks does Steve Myers hold?
Steve Myers holds: GB:AVO stocks.
What was Steve Myers’s latest transaction?
Steve Myers’s latest transaction was an Informative Buy of 8.75K .
What was Steve Myers's most profitable transaction?
Steve Myers’s most profitable transaction was an Informative Buy of GB:AVO stock on May 15, 2017. The return on the trade was 103.60%.
What is Steve Myers's role in Advanced Oncotherapy?
Steve Myers's role in Advanced Oncotherapy is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.